What Are Peptides?

Peptides are short chains of amino acids — the same building blocks that make up proteins. The difference is simply size: proteins are long chains (typically hundreds or thousands of amino acids), while peptides are short (usually between 2 and 50 amino acids). Think of it like this: if a protein is a full sentence, a peptide is a short phrase within that sentence.

Peptides occur naturally throughout the human body. Insulin is a peptide. So are endorphins, your body's natural painkillers. Growth hormone-releasing hormone (GHRH) is a peptide. Your body uses these molecules as signalling agents — they carry instructions between cells, telling them when to grow, repair, reduce inflammation, or release hormones.

Researchers became interested in synthesising (making in a lab) specific peptides because natural peptides are often quickly broken down in the body. By modifying the structure — sometimes changing a single amino acid — scientists can create synthetic versions that last longer, target specific receptors more precisely, and produce more predictable research outcomes.

How Do Peptides Work?

Most research peptides work by binding to specific receptors on the surface of cells, much like a key fitting into a lock. When the peptide (the key) binds to its receptor (the lock), it triggers a signalling cascade inside the cell — a chain reaction that leads to a biological effect.

Different peptides target different receptors and therefore produce different effects:

  • Tissue repair peptides (like BPC-157 and TB-500) interact with pathways involved in wound healing, angiogenesis (new blood vessel formation), and inflammation reduction.
  • Growth hormone secretagogues (like Ipamorelin and CJC-1295) bind to ghrelin or GHRH receptors in the pituitary gland, stimulating the body's own growth hormone release.
  • Metabolic peptides (like MOTS-c) act on cellular energy pathways, influencing how cells process glucose and respond to exercise.

The key principle is that peptides are signalling molecules — they instruct the body to do something it already does naturally, just more of it or in a targeted way. This is fundamentally different from, say, anabolic steroids, which directly introduce exogenous hormones.

Commonly Researched Peptide Categories

Healing and Tissue Repair

Peptides in this category are studied for their potential to accelerate recovery from injury, reduce inflammation, and support repair of tendons, ligaments, muscle, and other tissues. The most commonly discussed are:

  • BPC-157 — derived from human gastric juice, studied for tendon, ligament, and gut healing.
  • TB-500 — a fragment of thymosin beta-4, studied for wound healing, tissue repair, and anti-inflammatory effects.

Growth Hormone Secretagogues

These peptides stimulate the body's own growth hormone release, which in turn affects body composition, recovery, and cellular repair. Key examples:

  • Ipamorelin — a selective GHS noted for minimal cortisol and prolactin effects.
  • CJC-1295 — a GHRH analogue that extends the duration of natural GH pulses.
  • Sermorelin — a shorter GHRH analogue, sometimes used in clinical settings.

Metabolic and Longevity

  • MOTS-c — a mitochondrial-derived peptide studied for its effects on metabolic regulation, exercise capacity, and insulin sensitivity.

Key Safety Principles

If you are new to peptides, the following principles are essential:

1. Research Use Only

All peptides discussed on this site are sold and intended for research purposes. They are not licensed medicines in the UK and have not been approved for human therapeutic use by the MHRA. Nothing on this site constitutes medical advice.

2. Source Quality Matters Enormously

The purity and quality of research peptides varies dramatically between suppliers. Peptides should be purchased only from vendors that provide third-party Certificates of Analysis (COAs) verifying purity. Low-quality or contaminated peptides can introduce significant risks. See our Vendor Vetting Guide for detailed criteria.

3. Reconstitution Requires Care

Most peptides arrive as lyophilised (freeze-dried) powder and must be reconstituted with bacteriostatic water before use. This process requires sterile technique and careful handling. See our Reconstitution Guide (coming soon) for step-by-step instructions.

4. Blood Work Is Essential

Any research protocol involving peptides should be accompanied by regular blood work to monitor relevant biomarkers. This is the only objective way to assess physiological effects and detect potential issues early. See our Blood Work Interpretation Guide for details.

5. Less Is Often More

Peptides are potent signalling molecules. Higher doses do not necessarily produce better results and may increase the risk of side effects. The most commonly discussed protocols start low and adjust based on response.

UK Legal Status — The Basics

Research peptides are legal to purchase and possess in the UK for legitimate research purposes. They are not classified as controlled substances. However, they are not licensed medicines — they have not been approved by the MHRA (Medicines and Healthcare products Regulatory Agency) for human therapeutic use.

This means:

  • You can legally buy and possess peptides for research.
  • Vendors sell them as 'research chemicals, not for human consumption'.
  • They are not subject to the same quality, safety, and manufacturing regulations as licensed pharmaceuticals.
  • You cannot legally sell or market them as treatments for medical conditions.

For a detailed discussion of the regulatory landscape, see our UK Legality Guide.

What to Read Next

If you've read this far, here's our suggested reading order:

  1. Pick a compound — start with BPC-157 (healing) or Ipamorelin (growth hormone) to understand how a full compound profile works.
  2. Read the UK Legality Guide — understand the regulatory framework before purchasing anything.
  3. Read the Vendor Vetting Guide — learn how to evaluate suppliers and avoid low-quality products.
  4. Read the Blood Work Guide — understand which markers to monitor and why.

A Final Note

The field of peptide research is evolving rapidly. New compounds are being studied, new mechanisms are being understood, and the evidence base is growing — but slowly. Much of what is commonly discussed in peptide communities is based on animal studies, in vitro research, and anecdotal reports rather than robust human clinical trials.

Our aim at Peptide Data is to present what is known, flag what isn't, and help you make informed decisions about research. We will always be transparent about evidence quality. If a claim isn't supported by peer-reviewed research, we'll say so.

If you have questions or suggestions for content, we welcome feedback through our contact page.